- Home
- BTM vs LGVN Comparison
BTM vs LGVN Comparison
Compare BTM & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTM
- LGVN
- Stock Information
- Founded
- BTM 2016
- LGVN 2014
- Country
- BTM United States
- LGVN United States
- Employees
- BTM N/A
- LGVN N/A
- Industry
- BTM Finance: Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- BTM Finance
- LGVN Health Care
- Exchange
- BTM Nasdaq
- LGVN Nasdaq
- Market Cap
- BTM 144.5M
- LGVN 23.4M
- IPO Year
- BTM N/A
- LGVN 2021
- Fundamental
- Price
- BTM $5.42
- LGVN $1.43
- Analyst Decision
- BTM Strong Buy
- LGVN Strong Buy
- Analyst Count
- BTM 2
- LGVN 3
- Target Price
- BTM $4.75
- LGVN $8.67
- AVG Volume (30 Days)
- BTM 1.9M
- LGVN 710.2K
- Earning Date
- BTM 08-12-2025
- LGVN 08-13-2025
- Dividend Yield
- BTM N/A
- LGVN N/A
- EPS Growth
- BTM N/A
- LGVN N/A
- EPS
- BTM N/A
- LGVN N/A
- Revenue
- BTM $599,390,000.00
- LGVN $2,225,000.00
- Revenue This Year
- BTM $10.59
- LGVN N/A
- Revenue Next Year
- BTM $4.27
- LGVN $51.48
- P/E Ratio
- BTM N/A
- LGVN N/A
- Revenue Growth
- BTM N/A
- LGVN 127.50
- 52 Week Low
- BTM $0.93
- LGVN $1.14
- 52 Week High
- BTM $6.88
- LGVN $4.94
- Technical
- Relative Strength Index (RSI)
- BTM 56.75
- LGVN 59.84
- Support Level
- BTM $4.70
- LGVN $1.27
- Resistance Level
- BTM $6.21
- LGVN $1.40
- Average True Range (ATR)
- BTM 0.48
- LGVN 0.11
- MACD
- BTM -0.09
- LGVN 0.04
- Stochastic Oscillator
- BTM 58.39
- LGVN 61.40
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.